X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-01 | AGIO | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $43.85 | -3,705 | 43,736 | -8% | -$162,464 | |||||
| D | 2024-03-05 | AGIO | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $32.57 | -2,642 | 39,066 | -6% | -$86,050 | |||||
| D | 2024-02-14 | AGIO | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $25.14 | -642 | 33,431 | -2% | -$16,140 | |||||
| D | 2024-01-24 | AGIO | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $21.64 | -1,708 | 31,911 | -5% | -$36,961 | |||||
| D | 2024-01-09 | AGIO | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $22.99 | -1,789 | 27,869 | -6% | -$41,129 | |||||
| D | 2023-06-30 | AGIO | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $28.36 | -1,707 | 24,159 | -7% | -$48,411 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |